Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors-Reference-Cited by-同舟云学术

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

Published:2016-06 Issue:6 Volume:44 Page:1255-1269
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Pitt Jonathan M.,Vétizou Marie,Daillère Romain,Roberti María Paula,Yamazaki Takahiro,Routy Bertrand,Lepage Patricia,Boneca Ivo Gomperts,Chamaillard Mathias,Kroemer Guido,Zitvogel Laurence

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference167 articles.

1. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discov.,2013

2. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma;Ansell;N. Engl. J. Med.,2015

3. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat. Med.,2007

4. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans;Arbour;Nat. Genet.,2000

5. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation;Arpaia;Nature,2013

Cited by 821 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photoimmunotherapy for cancer treatment based on organic small molecules: Recent strategies and future directions;Translational Oncology;2024-11

2. Formulating a TMEM176B blocker in chitosan nanoparticles uncouples its paradoxical roles in innate and adaptive antitumoral immunity;International Journal of Biological Macromolecules;2024-11

3. Nonsense-Mediated mRNA Decay in Human Health and Diseases: Current Understanding, Regulatory Mechanisms and Future Perspectives;Molecular Biotechnology;2024-09-12

4. The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies;Future Oncology;2024-09-04

5. Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy;Heliyon;2024-09